Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
LUMO Lumos Pharma (Delisted)
- 4.340
- 0.0000.00%
Close Dec 11 16:00 ET
37.54MMarket Cap-1.01P/E (TTM)
0.000High0.000Low0Volume0.000Open4.340Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)8.65MShares4.57652wk High7.64P/B25.36MFloat Cap1.37052wk Low--Dividend TTM5.84MShs Float36.720Historical High--Div YieldTTM0.00%Amplitude1.370Historical Low--Avg Price1Lot Size
Lumos Pharma (Delisted) Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 35.98%-5.01M | 4.56%-6.38M | -40.20%-12.89M | -16.80%-31.1M | -26.90%-7.39M | -41.69%-7.82M | 7.73%-6.69M | -14.49%-9.2M | 10.20%-26.62M | -0.26%-5.83M |
| Net income from continuing operations | 10.04%-7.47M | 15.45%-7.55M | -42.13%-10.44M | -9.57%-34.03M | -14.67%-9.46M | -14.47%-8.3M | -13.86%-8.93M | 4.84%-7.35M | -2.08%-31.06M | -46.20%-8.25M |
| Depreciation and amortization | -112.50%-1K | -77.78%2K | -77.78%2K | -10.20%44K | -48.57%18K | 100.00%8K | 550.00%9K | -25.00%9K | -77.42%49K | 34.62%35K |
| Other non cash items | --0 | --0 | 99.26%-1K | -1,407.69%-392K | ---30K | ---91K | ---135K | ---136K | ---26K | ---- |
| Change In working capital | 51,975.00%2.08M | -54.51%782K | -31.34%-3.03M | -53.96%965K | -14.96%1.55M | -99.65%4K | 6,511.54%1.72M | -159.55%-2.31M | 190.58%2.1M | 364.49%1.83M |
| -Change in receivables | -109.84%-6K | 140.63%13K | 31.82%29K | 114.13%13K | 13.64%-38K | 481.25%61K | -28.00%-32K | 414.29%22K | -167.65%-92K | -266.67%-44K |
| -Change in prepaid assets | 7.81%345K | 53.85%260K | 32.04%-437K | 38.01%679K | 42.39%833K | -32.20%320K | -61.33%169K | 35.83%-643K | 145.30%492K | 135.89%585K |
| -Change in payables and accrued expense | 562.60%1.74M | -67.83%509K | -55.48%-2.63M | -83.90%273K | -41.04%757K | -155.52%-377K | 509.84%1.58M | -1,519.33%-1.69M | 224.34%1.7M | 238.66%1.28M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 35.98%-5.01M | 4.56%-6.38M | -40.20%-12.89M | -16.80%-31.1M | -26.90%-7.39M | -41.69%-7.82M | 7.73%-6.69M | -14.49%-9.2M | 10.20%-26.62M | -0.26%-5.83M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 140.60%1M | 194.58%10.74M | 154.34%6.17M | 5.95M | 1.08M | -2.46M | -143.74%-11.36M | -37,760.00%-11.36M |
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 30.00%-21K | ---- |
| Net investment purchase and sale | --0 | --0 | 140.60%1M | 194.75%10.74M | 154.44%6.17M | --5.95M | --1.08M | ---2.46M | ---11.34M | ---11.34M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 140.60%1M | 194.58%10.74M | 154.34%6.17M | --5.95M | --1.08M | ---2.46M | -143.74%-11.36M | -37,760.00%-11.36M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 496.78%1.73M | 0 | 98.38%-5K | 29.84%-576K | 256.21%742K | -33.44%-435K | -28,600.00%-574K | -1,616.67%-309K | -327.60%-821K | -475K |
| Net common stock issuance | 506.10%1.73M | --0 | --0 | 13.33%-585K | 251.67%725K | -116.24%-426K | ---579K | ---305K | ---675K | ---478K |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | -60.67%35K | -29.17%17K | --0 | ---- | ---- | 27.14%89K | --24K |
| Net other financing activities | 55.56%-4K | 15.38%-11K | -25.00%-5K | 88.94%-26K | --0 | 94.51%-9K | 59.38%-13K | 77.78%-4K | 10.31%-235K | ---21K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 496.78%1.73M | --0 | 98.38%-5K | 29.84%-576K | 256.21%742K | -33.44%-435K | -28,600.00%-574K | -1,616.67%-309K | -327.60%-821K | ---475K |
| Net cash flow | ||||||||||
| Beginning cash position | -55.63%16.8M | -47.37%23.18M | -37.37%35.08M | -40.93%56.01M | -51.73%35.56M | -52.38%37.86M | -49.24%44.04M | -40.93%56.01M | -3.92%94.81M | -26.81%73.67M |
| Current changes in cash | -42.30%-3.28M | -3.30%-6.38M | 0.58%-11.9M | 46.06%-20.93M | 97.29%-479K | 60.56%-2.31M | 14.78%-6.18M | -48.66%-11.97M | -902.64%-38.8M | -202.33%-17.66M |
| End cash Position | -61.98%13.52M | -55.63%16.8M | -47.37%23.18M | -37.37%35.08M | -37.37%35.08M | -51.73%35.56M | -52.38%37.86M | -49.24%44.04M | -40.93%56.01M | -40.93%56.01M |
| Free cash flow | 35.98%-5.01M | 4.56%-6.38M | -40.20%-12.89M | -16.71%-31.1M | -26.44%-7.39M | -41.69%-7.82M | 7.73%-6.69M | -14.49%-9.2M | 10.22%-26.64M | -0.10%-5.85M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.